Decision to list laboratory equipment and consumables supplied by In Vitro Technologies NZ Pty Limited
We are pleased to announce the approval of listing agreements for the supply of medical devices to DHBs.
What we’re doing
We are pleased to announce the approval of a listing agreement with In Vitro Technologies NZ Pty Limited (“In Vitro”) for the supply of:
In summary this will result in:
- In Vitro’s laboratory equipment and consumables being listed in Part III of Section H of the Pharmaceutical Schedule from 1 April 2022 under a national agreement that all DHBs may purchase under (“Agreement”); and
- DHBs being able to continue to purchase other suppliers’ brands of laboratory equipment and consumables.
Any changes to the original proposal?
This decision was subject to a consultation letter dated 18 January 2022.
The Stockwell product range was removed from the proposal and pricing was updated for two product ranges during the consultation period.
Who we think will be most interested
- DHB Staff
- Clinical Engineers and maintenance services
- Clinical Product Evaluators
- Laboratory managers, scientists, technicians and other laboratory staff
- Procurement Officers and supply chain personnel
- Suppliers and wholesalers
Details about this decision
In September 2018, Pharmac issued a Request for Proposal (“RFP”) for the supply of laboratory equipment and consumables for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers who responded to the RFP to seek provisional agreements and this is the first proposal to be contracted as a result of the laboratory equipment and consumables RFP. We are continuing to negotiate contracts with other suppliers of laboratory equipment and consumables.
The list of products will be available on PHARMAC’s website from 1 April 2022, in both PDF and Excel spreadsheet formats.
DHBs can continue to choose which laboratory equipment and consumables they purchase, including those from other suppliers. DHBs that purchase laboratory equipment and consumables from Olympus must do so under the terms and conditions, including pricing, in the Pharmac Agreement from 1 April 2022.
We expect to consult further with suppliers of laboratory equipment and consumables throughout 2022.
Our response to what you told us
We appreciate the time people took to respond to this consultation.
All consultation responses received by 14 February 2022 were considered in their entirety in making the decision to list In Vitro’s laboratory equipment and consumables.
A summary of the main themes raised in feedback and our responses to the feedback are set out below:
No technical or resource impacts anticipated as a result of the proposal.
Feedback was received about the price of two product ranges included in the provisional agreement.
The feedback was discussed with the supplier and updated information and pricing was provided to DHB Procurement Managers during the consultation period.
|Support and endorsement for the proposal as it is not for sole supply of laboratory equipment and consumables.||Noted.|
If you have any questions about this decision, you can email us at firstname.lastname@example.org; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.